John Tsai, Head of Global Drug Development and Chief Medical Officer, describes how he balances innovation and patient needs.

With extensive experience in public health management, having worked for the International Red Cross, among others, and as a doctor in emergency situations on the ground in Africa and Asia— Ann Aerts discusses the Novartis Foundation's new leprosy strategy.

Jay Bradner discusses his vision for an open framework of scientific discovery at Novartis.

The race is on to find a new treatment before resistance to today’s drugs becomes widespread.

Novartis researchers are learning how a novel approach to immunotherapy could help treat cancer.

New Global Head of Ophthalmology Research sees the eye as a frontier of biomedical research.

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.

Lutz Hegemann shares how lessons learned treating patients with leprosy influenced the way he thinks about the pharmaceutical business.

We’re working to bring the hope of advanced medicine to more patients.

Jennifer Leeds offers a behind-the-scenes look at the consortia forming to address COVID-19.